No Superiority of Treatment With Osmotic Controlled-Release Oral Delivery System-Methylphenidate Over Short/Medium-Acting Methylphenidate Preparations in the Rate and Timing of Injuries in Children With Attention-Deficit/Hyperactivity Disorder

Golubchik, P; Kodesh, A; Weizman, A

Golubchik, P (reprint author), Geha Mental Hlth Ctr, Child & Adolescent Outpatient Clin, Petah Tiqwa, Israel.

CLINICAL NEUROPHARMACOLOGY, 2017; 40 (1): 11

Abstract

Objectives: Methylphenidate (MPH) treatment in patientswith attention-deficit/hyperactivity disorder (ADHD) is reported to reduce the risk for injurie......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索